Pasar al contenido principal

REDES DE SEÑALIZACION DE GRK2 Y MECANISMOS MOLECULARES DE PROCESOS PATOLOGICOS

PID2020-117218RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Efficient terminal erythroid differentiation requires the APC/C cofactor Cdh1 to limit replicative stress in erythroblasts

  • Cuadrado, Myriam
  • Garzón, Javier
  • Moreno, Sergio
  • García-Higuera, Irene
The APC/C-Cdh1 ubiquitin ligase complex drives proteosomal degradation of cell cycle regulators and other cellular proteins during the G1 phase of the cycle. The complex serves as an important modulator of the G1/S transition and prevents premature entry into S phase, genomic instability, and tumor development. Additionally, mounting evidence supports a role for this complex in cell differentiation, but its relevance in erythropoiesis has not been addressed so far. Here we show, using mouse models of Cdh1 deletion, that APC/C-Cdh1 activity is required for efficient terminal erythroid differentiation during fetal development as well as postnatally. Consistently, Cdh1 ablation leads to mild but persistent anemia from birth to adulthood. Interestingly, loss of Cdh1 seems to affect both, steady-state and stress erythropoiesis. Detailed analysis of Cdh1-deficient erythroid populations revealed accumulation of DNA damage in maturing erythroblasts and signs of delayed G2/M transition. Moreover, through direct assessment of replication dynamics in fetal liver cells, we uncovered slow fork movement and increased origin usage in the absence of Cdh1, strongly suggesting replicative stress to be the underlying cause of DNA lesions and cell cycle delays in erythroblasts devoid of Cdh1. In turn, these alterations would restrain full maturation of erythroblasts into reticulocytes and reduce the output of functional erythrocytes, leading to anemia. Our results further highlight the relevance of APC/C-Cdh1 activity for terminal differentiation and underscore the need for precise control of replication dynamics for efficient supply of red blood cells., This research was funded by grants from the Spanish Ministry of Economy and Competitiveness MINECO (BFU2014-55439 and BFU2017-88335-R), from the Castile and Leon government (CSI151U13, CSI259P20 and IBFG Unit of Excellence programs CLU-2017-03 and CL-EI-2021-08 co-funded by the P.O. Feder of Castile and Leon 14-20 and European Union ERDF "Europe drives our growth") and from the Spanish Ministry of Science and Innovation-MICINN (PID2020-117218RB-I00). I.G.H was supported by Fundación Científica de la Asociación Española contra el Cáncer (AECC). MC held a CSIC JAE doctoral contract and J.G. was the recipient of a CSIC JAE predoctoral fellowships.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Greatwall-Endosulfine Switch Accelerates Autophagic Flux during the Cell Divisions Leading to G1 Arrest and Entry into Quiescence in Fission Yeast

  • Vázquez-Bolado, Alicia
  • López-San Segundo, Rafael
  • García-Blanco, Natalia
  • Rozalén, Ana E.
  • González-Álvarez, Daniel
  • Suárez, M. Belén
  • Pérez-Hidalgo, Livia
  • Moreno, Sergio
Entry into quiescence in the fission yeast Schizosaccharomyces pombe is induced by nitrogen starvation. In the absence of nitrogen, proliferating fission yeast cells divide twice without cell growth and undergo cell cycle arrest in G1 before becoming G0 quiescent cells. Under these conditions, autophagy is induced to produce enough nitrogen for the two successive cell divisions that take place before the G1 arrest. In parallel to the induction of autophagy, the Greatwall–Endosulfine switch is activated upon nitrogen starvation to down-regulate protein phosphatase PP2A/B55 activity, which is essential for cell cycle arrest in G1 and implementation of the quiescent program. Here we show that, although inactivation of PP2A/B55 by the Greatwall–Endosulfine switch is not required to promote autophagy initiation, it increases autophagic flux at least in part by upregulating the expression of a number of autophagy-related genes., This work was funded by the Spanish Ministry of Science and Innovation-MICINN (grants BFU2017-88335-R and PID2020-117218RB-I00) and from the Castile and Leon government (grants CSI151U13 and CSI259P20 and IBFG Unit of Excellence programs CLU-2017-03 and CL-EI-2021-08 co-funded by the P.O. Feder of Castile and Leon 14-20 and European Union ERDF “Europe drives our growth”). N.G.-B., A.V.B. and D.G.-Á. were funded by FPU15/03654, BES-2015-073171, PRE2018-084956 predoctoral training contracts. R.L.-S.S. was funded by a predoctoral fellowship from the Castile and Leon governments., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Crosstalk between CXCR4/ACKR3 and EGFR Signaling in Breast Cancer Cells

  • Neves, María
  • Marolda, Viviana
  • Mayor, Federico
  • Penela, Petronila
A better understanding of the complex crosstalk among key receptors and signaling pathways involved in cancer progression is needed to improve current therapies. We have investigated in cell models representative of the major subtypes of breast cancer (BC) the interplay between the chemokine CXCL12/CXCR4/ACKR3 and EGF receptor (EGFR) family signaling cascades. These cell lines display a high heterogeneity in expression profiles of CXCR4/ACKR3 chemokine receptors, with a predominant intracellular localization and different proportions of cell surface CXCR4+, ACKR3+ or double-positive cell subpopulations, and display an overall modest activation of oncogenic pathways in response to exogenous CXCL12 alone. Interestingly, we find that in MDA-MB-361 (luminal B subtype, Her2-overexpressing), but not in MCF7 (luminal A) or MDA-MB-231 (triple negative) cells, CXCR4/ACKR3 and EGFR receptor families share signaling components and crosstalk mechanisms to concurrently promote ERK1/2 activation, with a key involvement of the G protein-coupled receptor kinase 2 (GRK2) signaling hub and the cytosolic tyrosine kinase Src. Our findings suggest that in certain BC subtypes, a relevant cooperation between CXCR4/ACKR3 and growth factor receptors takes place to integrate concurrent signals emanating from the tumor microenvironment and foster cancer progression., Our laboratories are supported by the European Union (H2020-MSCA Program, Grant agreement 860229-ONCORNET 2.0 to F.M.J.), Agencia Estatal de Investigación of Spain (grant PID2020-117218RB-I00 to F.M.J.), CIBERCV-Instituto de Salud Carlos III, Spain (grant CB16/11/00278 to F.M.J., co-funded with European FEDER contribution), Fundación Ramón Areces (to F.M.J. and P.P.), Instituto de Salud Carlos III (grant PI21-01834 to P.P., co-funded with European FEDER contribution), and Programa de Actividades en Biomedicina de la Comunidad de Madrid-B2017/BMD-3671-INFLAMUNE (to F.M.J.). F.M.J. is member of the ERNST CA18133 Cost Action.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Adrenergic modulation of neutrophil and macrophage functions: pathophysiological cues

  • Vida, Carmen
  • Portilla, Yadileiny
  • Murga, Cristina
In this review, we will summarize current and past findings on the adrenergic regulation of myeloid cell functions and dynamics, with special emphasis on the pathophysiological impact of such modulation. Adrenergic signaling has traditionally been described to be immunosuppressive, but some recent results are challenging this paradigm, in particular those related to in vivo models of stress and findings in human patients. Also, cumulative evidence reveals that the final pro- or anti-inflammatory outcome of adrenergic inputs in myeloid cells appears to be very dependent on the experimental setup utilized or on the cellular context (resting vs stimulated conditions, in vivo vs in vitro settings, mice vs human cells, health vs pathology). Varying doses and/or time points may result in seemingly contradictory results that depend on the nature of receptor engaged (α or β adrenergic receptor subtypes), the downstream cascades involved, the presence of additional stimulatory or inhibitory signals, and the actual kinetics of the process studied. We will thus address some of these apparently paradoxical findings, review several pathological settings in which adrenergic modulation of neutrophil or macrophage-mediated immunity is relevant, and discuss open questions that still remain unanswered., Our laboratory is funded by grants from the Agencia Estatal de Investigación Spain (grant PID2020-117218RB-I00), from Programas de Actividades de I+D Comunidad de Madrid Spain (INTEGRAMUNE, grant P2022/BMD-7209), and CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Spain (grant , CB16/11/00278co-funded with European FEDER contribution). C. Vida was a postdoctoral scholar under the Juan de la Cierva-Incorporación contract (IJC2020-045834-I) and Y. Portilla received a postdoctoral Juan de la Cierva-Formación contract (FJC2021-047015-I), both funded by MCIN/AEI/Plan de Recuperación, Transformación y Resiliencia, Spain.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

GRK2-mediated AKT activation controls cell cycle progression and G2 checkpoint in a p53-dependent manner

  • Rivas, Verónica
  • González-Muñoz, Teresa
  • Albitre, Ángela
  • Lafarga, Vanesa
  • Delgado-Arévalo, Cristina
  • Mayor, Federico
  • Penela, Petronila
Cell cycle checkpoints, activated by stressful events, halt the cell cycle progression, and prevent the transmission of damaged DNA. These checkpoints prompt cell repair but also trigger cell death if damage persists. Decision-making between these responses is multifactorial and context-dependent, with the tumor suppressor p53 playing a central role. In many tumor cells, p53 alterations lead to G1/S checkpoint loss and the weakening of the G2 checkpoint, rendering cell viability dependent on the strength of the latter through mechanisms not fully characterized. Cells with a strong pro-survival drive can evade cell death despite substantial DNA lesions. Deciphering the integration of survival pathways with p53-dependent and -independent mechanisms governing the G2/M transition is crucial for understanding G2 arrest functionality and predicting tumor cell response to chemotherapy. The serine/threonine kinase GRK2 emerges as a signaling node in cell cycle modulation. In cycling cells, but not in G2 checkpoint-arrested cells, GRK2 protein levels decline during G2/M transition through a process triggered by CDK2-dependent phosphorylation of GRK2 at the S670 residue and Mdm2 ubiquitination. We report now that this downmodulation in G2 prevents the unscheduled activation of the PI3K/AKT pathway, allowing cells to progress into mitosis. Conversely, higher GRK2 levels lead to tyrosine phosphorylation by the kinase c-Abl, promoting the direct association of GRK2 with the p85 regulatory subunit of PI3K and AKT activation in a GRK2 catalytic-independent manner. Hyperactivation of AKT is conditioned by p53’s scaffolding function, triggering FOXO3a phosphorylation, impaired Cyclin B1 accumulation, and CDK1 activation, causing a G2/M transition delay. Upon G2 checkpoint activation, GRK2 potentiates early arrest independently of p53 through AKT activation. However, its ability to overcome the G2 checkpoint in viable conditions depends on p53. Our results suggest that integrating the GRK2/PI3K/AKT axis with non-canonical functions of p53 might confer a survival advantage to tumor cells., Our laboratory is supported by Instituto de Salud Carlos III, Spain (Grant PI21-01834 to PP), with FEDER co-financing and Fundación Ramón Areces (Grant CIVP20S10772 to PP) and Agencia Estatal de Investigación of Spain (Grant PID2020-117218RB-I00 to FM). The work was also supported by CIBERCV-Instituto de Salud Carlos III, Spain (Grant CB16/11/00278, co-funded with European FEDER contribution) and INTEGRAMUNE-CM (Grant P2022/BMD-7209). We also acknowledge institutional support to the CBMSO from Fundación Ramón Areces and MINECO (SEV-2016-0644) for the Severo Ochoa Excellence Accreditation.